Lowell T. Harmison Ph.D.
Board Chairman

Dr. Lowell Harmison is a founding director of the WorldDoc Charitable, Education and Research Foundation. Dr. Harmison has over 45 years of experience and leadership in biomedicine as a researcher, inventor, author, U.S. Government Senior Executive and foundation and corporate executive roles in both private and public companies. His work includes a decade of research at the National Institute of Health, a decade of service as the U.S. PHS Science Advisor and Principal Deputy Assistant Secretary of Health, DHHS; and two decades of private foundation and corporation work on a global scale.

Dr. Harmison holds degrees from MIT Sloan School of Management, Post Doctoral Physiology from the University of Michigan, Ph.D. from the University of Maryland, M.S. and B.S. from West Virginia University, The Federal Institute of Charlottesville, VA and an Honorary Doctor of Science from WVU.

Dr. Harmison’s principal scientific achievements include:
(a) developing and testing the first completely implantable artificial assist heart to augment the function of the diseased heart and the totally implantable artificial heart (Dr. Harmison holds the first U.S. and foreign patent for the completely implantable artificial heart, No. 3,919,722);
(b) leading the development of the HIV/AIDS blood test from the laboratory stage to an FDA approved and licensed commercial blood test for the AIDS virus that the American Red Cross used to screen the American blood supply for the HIV virus;
(c) developing and testing the first experimental method for the extension of neutron activation analysis to non-activatable trace elements in blood and other media; and
(d) producing the first work in the United States on radiation-induced polymerization of selected monomers with cellulose.

Since 1990, Dr. Harmison has been a Senior Advisor and board member to pharmaceutical and health companies, foundations and governments. The work has focused on discovery, R/D, new products and business strategies for corporate profitability, growth, and stability. It has included regulatory work, clinical trials, product development, and growth strategies as well as advising governments on health and environmental programs and policies. He has participated in founding four biomedical companies and two medical foundations.

Dr. Harmison now serves as a senior executive advisor to the Hasumi International Research Foundation, Dean of the International Academy of Artificial Organ Pioneers, and adjunct professor at the University of Maryland. Dr. Harmison has authored over 100 publications, edited two books and most recently co-authored the book Zeroing in on the Cancer Cell: Cancer Vaccines. He has also presented more than 500 lectures around the world.